» Authors » Rafael Luque-Marquez

Rafael Luque-Marquez

Explore the profile of Rafael Luque-Marquez including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 24
Citations 89
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Cuervo G, Hernandez-Meneses M, de Alarcon A, Luque-Marquez R, Alonso-Socas M, Lopez-Lirola A, et al.
Infect Dis Ther . 2025 Mar; PMID: 40024946
Introduction: The POET trial demonstrated that moving from intravenous to oral antibiotics in stable patients with left-sided infective endocarditis (IE) was noninferior to fully parenteral treatment. However, it did not...
2.
Francisco L, Luque-Marquez R, Mejias-Trueba M, Herrera-Hidalgo L, Gil-Navarro M
Farm Hosp . 2024 Jun; 48(5):T259-T261. PMID: 38906718
No abstract available.
3.
Fernandez-Rubio B, Herrera-Hidalgo L, de Alarcon A, Luque-Marquez R, Lopez-Cortes L, Luque S, et al.
Pharmaceutics . 2023 Dec; 15(12). PMID: 38140046
Outpatient parenteral antimicrobial therapy (OPAT) is a useful treatment strategy against and other multidrug-resistant bacteria. However, it is hindered by the lack of stability data for the administration of antibiotics...
4.
Paniagua-Garcia M, Casimiro-Soriguer C, Chinchon D, Navarro-Amuedo M, Luque-Marquez R, de Alava E, et al.
Clin Microbiol Infect . 2023 Dec; 30(3):395.e1-395.e4. PMID: 38042367
Objective: Human monkeypox (mpox) is usually self-limited infection; however, rising data show a worse outcome in patients with impaired immune status, particularly those co-infected with HIV [Mitjà O, Alemany A,...
5.
Herrera-Hidalgo L, Munoz P, Alvarez-Uria A, Alonso-Menchen D, Luque-Marquez R, Gutierrez-Carretero E, et al.
Int J Infect Dis . 2023 Nov; 137:134-143. PMID: 37926195
Objectives: This study aimed to assess the real use of cefazolin for methicillin-susceptible Staphylococcus aureus (MSSA) infective endocarditis (IE) in the Spanish National Endocarditis Database (GAMES) and to compare it...
6.
Fernandez-Rubio B, Herrera-Hidalgo L, Lopez-Cortes L, Luque-Marquez R, de Alarcon A, Luque-Pardos S, et al.
J Antimicrob Chemother . 2023 Aug; 78(10):2451-2456. PMID: 37574704
Background: Temocillin is an interesting alternative to carbapenems for susceptible Enterobacteriaceae. Although its use in outpatient parenteral antimicrobial therapy (OPAT) programmes has generated interest, this has been hampered by the...
7.
Herrera-Hidalgo L, Fernandez-Rubio B, Luque-Marquez R, Lopez-Cortes L, Gil-Navarro M, de Alarcon A
Antibiotics (Basel) . 2023 Apr; 12(4). PMID: 37107066
Today, is one of the main causes of infective endocarditis in the world, generally affecting an elderly and fragile population, with a high mortality rate. Enterococci are partially resistant to...
8.
Fernandez-Rubio B, Herrera-Hidalgo L, Luque-Marquez R, de Alarcon A, Lopez-Cortes L, Luque-Pardos S, et al.
Antibiotics (Basel) . 2023 Mar; 12(3). PMID: 36978299
Currently, ampicillin plus ceftriaxone (AC) is one of the preferred treatments for infective endocarditis. However, there is a lack of stability data for the combination of both drugs in elastomeric...
9.
Gomez-Martin M, Rodriguez-Benjumeda L, de Eguilior-Mestre M, Lozano-Dominguez M, Luque-Marquez R, Jodar-Sanchez F, et al.
Gac Sanit . 2023 Feb; 37:102288. PMID: 36804781
Objective: To find out whether the leptospirosis incidence rate among red swamp crayfish collectors in the harvesting season is higher than in the general population, and to identify risk factors...
10.
Herrera-Hidalgo L, Luque-Marquez R, de Alarcon A, Guisado-Gil A, Gutierrez-Gutierrez B, Navarro-Amuedo M, et al.
J Clin Med . 2022 Mar; 11(6). PMID: 35329878
Cefazolin is a recommended treatment for methicillin-susceptible Staphylococcus aureus (MSSA) infections that has been successfully used in outpatient parenteral antibiotic therapy (OPAT) programs. The aim of this study was to...